Hengkang Medical Group Co., Ltd.

Shenzhen Stock Exchange 002219.SZ

Hengkang Medical Group Co., Ltd. Revenue for the year ending December 31, 2023: USD 505.72 M

Hengkang Medical Group Co., Ltd. Revenue is USD 505.72 M for the year ending December 31, 2023, a 10.69% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Hengkang Medical Group Co., Ltd. Revenue for the year ending December 31, 2022 was USD 456.86 M, a -3.75% change year over year.
Hengkang Medical Group Co., Ltd. Revenue for the year ending December 31, 2021 was USD 474.67 M, a 10.42% change year over year.
Hengkang Medical Group Co., Ltd. Revenue for the year ending December 31, 2020 was USD 429.86 M, a -18.75% change year over year.
Hengkang Medical Group Co., Ltd. Revenue for the year ending December 31, 2019 was USD 529.09 M, a -5.20% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shenzhen Stock Exchange: 002219.SZ

Hengkang Medical Group Co., Ltd.

CEO	Mr. Liu Jun
IPO Date	March 6, 2008
Location	China
Headquarters	Jinjiang Industrial Development Zone
Employees	7,803
Sector	Health Care
Industries Pharmaceuticals Hospitals & Clinics Medical Instruments

Description

Hengkang Medical Group Co.,Ltd provides medical services, pharmaceuticals, health care, and daily chemical products in China and internationally. It operates approximately 11 hospitals. The company also manufactures pharmaceutical products in the areas of analgesia, cold, cough, gynecology, cardiovascular, digestive, and urinary systems. In addition, it offers Chinese herbal medicines, infusion, and hemostasis products, as well as daily chemical products. The company was formerly known as Gansu Duyiwei Biological Pharmaceutical Co., Ltd. and changed its name to Hengkang Medical Group Co.,Ltd in January 2014. Hengkang Medical Group Co.,Ltd. was founded in 2001 and is based in Chengdu, China.

Key trends

Past 5 years